Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights
Nanomaterials · 12.04.2024 · 14 (8) · 672
DOI: 10.3390/nano14080672 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 12.04.2024. Verfasst von Shery Jacob und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University, Ajman 4184, United Arab Emirates. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gulf Medical University, Ajman, United Arab Emirates.
Abstract (Originalsprache)
Curcumin, an organic phenolic molecule that is extracted from the rhizomes of Curcuma longa Linn, has undergone extensive evaluation for its diverse biological activities in both animals and humans. Despite its favorable characteristics, curcumin encounters various formulation challenges and stability issues that can be effectively addressed through the application of nanotechnology. Nano-based techniques specifically focused on enhancing solubility, bioavailability, and therapeutic efficacy while mitigating toxicity, have been explored for curcumin. This review systematically presents information on the improvement of curcumin’s beneficial properties when incorporated, either individually or in conjunction with other drugs, into diverse nanosystems such as liposomes, nanoemulsions, polymeric micelles, dendrimers, polymeric nanoparticles, solid-lipid nanoparticles, and nanostructured lipid carriers. Additionally, the review examines ongoing clinical trials and recently granted patents, offering a thorough overview of the dynamic landscape in curcumin delivery. Researchers are currently exploring nanocarriers with crucial features such as surface modification, substantial loading capacity, biodegradability, compatibility, and autonomous targeting specificity and selectivity. Nevertheless, the utilization of nanocarriers for curcumin delivery is still in its initial phases, with regulatory approval pending and persistent safety concerns surrounding their use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University, Ajman 4184, United Arab Emirates.
- Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
- Department of Pharmacology, Faculty of Medicine, Minia University, El-Minia 61511, Egypt.
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
- Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
- Department of Pharmaceutics, Institute of Pharmacy, Nirma University, Ahmedabad 382481, India.
ORCID-Profile: Shery Jacob, Fathima Sheik Kather, Mohamed A Morsy, Sai H S Boddu, Mahesh Attimarad, Jigar Shah, Pottathil Shinu, Anroop B Nair
Förderung
- Gulf Medical University, Ajman, United Arab Emirates
Zitieren
APA
Jacob, S., Kather, F. S., Morsy, M. A., Boddu, S. H. S., Attimarad, M., Shah, J., Shinu, P., & Nair, A. B. (2024). Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights. Nanomaterials, 14(8), 672. https://doi.org/10.3390/nano14080672
Vancouver
Jacob S, Kather FS, Morsy MA, Boddu SHS, Attimarad M, Shah J, et al. Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights. Nanomaterials. 2024;14(8):672. doi:10.3390/nano14080672
BibTeX
@article{Jacob2024,
author = {Jacob, Shery and Kather, Fathima Sheik and Morsy, Mohamed A and Boddu, Sai H S and Attimarad, Mahesh and Shah, Jigar and Shinu, Pottathil and Nair, Anroop B},
title = {Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights},
journal = {Nanomaterials},
year = {2024},
volume = {14},
number = {8},
pages = {672},
doi = {10.3390/nano14080672}
}
EUVIMED